Comparative Analgesic Effect After Total Knee Arthroplasty Between Intraosseous and Peri-articular Injection
- Conditions
- Pain PostoperativeTotal Knee AnthroplastyFunctional Outcomes
- Registration Number
- NCT06800846
- Lead Sponsor
- Thammasat University Hospital
- Brief Summary
The goal of this RCT is to compare analgesic effect after total knee arthroplasty between intraosseous multimodal analgesic agent injection versus periarticular injection. The main question\[s\] it aims to answer are: Does Intraosseous multimodal analgesic cocktail injection have more post-operative analgesic effect than Peri-articular injection in patients who have done TKA (P)? Participants will randomized to intraosseous injection group or peri-articular injection group and will record the 100-mm VAS pain scores for 2 weeks after TKA. Researchers will compare to peri-articular injection group to see pain and functional outcomes after TKA.
- Detailed Description
Intra-operatively, you will be randomly assigned to receive intraosseous multimodal analgesic agent injection or peri-articular multimodal analgesic agent injection along with other standard medications. In the intraosseous injection group: Participants received combinations of 0.5% bupivacaine 100 mg + 0.1% adrenaline 0.6 mg + Morphine 5mg + Ketorolac 30 mg (totally 22 ml) which divided by 12 ml inject into intramedullary canal before bone plug impaction to close the canal and 10 ml inject into metaphysis of tibia before cementation and implantation. In the peri-articualr injection group: Participants received combinations of the same drug and mix with normal saline solution for totally 75 ml which divided by 25 ml inject into medial gutter and 25 ml inject into lateral gutter before cementation and implantation. And the last 25 ml of multimodal analgesic drugs were injected into quadriceps.
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 90
- 50 - 80 yrs of age ASA classification: 1-3 Unilateral TKA
- Secondary OA knee Previous knee surgery Can't undertaken spinal block and adductor canal block Renal insuf. (Crcl < 30 ml/min) History of convulsive disorder Abnormal liver function BMI > 35 Kg/M2 Allergy to study drugs History of coronary disease Hb < 10 (g/dl) Can't understand 100mm-VAS assessment Refuse to recruit in the study, or refuse follow up Using opioid in 5 days before surgery Unstable vital sign History current VTE Using anti-platelet or anti-coagulation medicine Severe deformity
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method pain scores at 4, 6 hours and every 6 hours after surgery for 2 days, then daily for 2 weeks after surgery. Visual analog scale at rest and motion (0-100 points, 0 mean best, 100 mean worst)
- Secondary Outcome Measures
Name Time Method Number of other Events of Morphine side effect 2 weeks after surgery Itching, rash, constipation, difficult urination, respiratory, etc.
ROM before surgery and 24, 48hours and 2 weeks after surgery ROM (degree)
Length of stays in hospital up to 72 hours Number of hours the patient stays for surgery
Number of other complication 2 weeks clinical VTE, wound and skin complication, superficial and deep infection
Morphine consumption 2 weeks Morphine consumption in hospital 48 hours before discharge and MST as home medication for 2 weeks (MME)
Timed up and go test at 48 hours and 2 weeks after surgery start with standing and then walk for 3 meters, then turn back to seat for 3 meters, then sit (report in seconds)
Time to walk up to 48 hours hours after surgery of patients at first start walking to the toilet
number of vomit events at first 48 hours before discharge and after discharge for 2 weeks after surgery number of vomit events
Operative time up to 2 hours duration from start incision to wound closure in TKA procedure (minutes)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Thammasat University Hospital
🇹ðŸ‡Khlong Luang, Pathum Thani, Thailand